Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 120 /hr
Hire Dr. Arndt B.
Germany
USD 120 /hr
Pharma-professional with 17 years of experience in cancer target discovery and biomarker development
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Medical Writing,
Technical Writing
Research
Market Research,
User Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Scientific and Technical Consulting
Data & AI
Predictive Modeling,
Statistical Analysis,
Algorithm Design-Non ML,
Data Visualization,
Big Data Analytics,
Data Processing,
Data Insights
Product Development
Formulation,
Product Evaluation,
Product Validation,
Concept Development,
Prototyping
Work Experience
Managing Director
VeViVas GmbH
June 2017 - Present
Biomarker expert / Senior investigator
Novartis Institutes for BioMedical Research Basel
July 2008 - March 2017
Section head
Novartis Institutes for BioMedical Research Basel
April 2007 - June 2008
labhead computatonal biology
Novartis Pharma AG
April 2001 - March 2007
Postdoc
Novartis
February 1999 - March 2001
Postdoc
Biozentrum
August 1997 - December 1998
Education
PhD Genetics, summa cum laude
Biozentrum der Universität Basel, Switzerland
January 1994 - June 1997
Diplom Biologie
Ludwig Maximilian University of Munich
September 1987 - June 1993
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2017). Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy . Arthritis research & therapy.
(2015). Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity . Pediatric rheumatology online journal.
(2013). Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial . Lancet (London, England).
(2011). A microarray analysis of full depth knee cartilage of ovariectomized rats . BMC research notes.
(2008). Modulation of drug resistance by artificial transcription factors . Molecular cancer therapeutics.
(2006). PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway . Experimental cell research.
(2005). Genetic reprogramming of tumor cells by zinc finger transcription factors . Proceedings of the National Academy of Sciences of the United States of America.
(2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis . Cancer research.
(2002). A microarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosis . Oncogene.
(2002). Reorientation of mispositioned spindles in short astral microtubule mutant spc72Delta is dependent on spindle pole body outer plaque and Kar3 motor protein . Molecular biology of the cell.
(2000). Comparative microarray analysis of gene expression during apoptosis-induction by growth factor deprivation or protein kinase C inhibition . Oncogene.
(2000). Time-lapse video microscopy analysis reveals astral microtubule detachment in the yeast spindle pole mutant cnm67 . Molecular biology of the cell.
(2000). Analysis of deletion phenotypes and GFP fusions of 21 novel Saccharomyces cerevisiae open reading frames. Yeast (Chichester, England).
(1998). Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast (Chichester, England).
(1998). Saccharomyces cerevisiae cells with defective spindle pole body outer plaques accomplish nuclear migration via half-bridge-organized microtubules . Molecular biology of the cell.
(1997). Heterologous HIS3 marker and GFP reporter modules for PCR-targeting in Saccharomyces cerevisiae. Yeast (Chichester, England).
(1996). Stepwise assembly of the lipid-linked oligosaccharide in the endoplasmic reticulum of Saccharomyces cerevisiae: identification of the ALG9 gene encoding a putative mannosyl transferase . Proceedings of the National Academy of Sciences of the United States of America.
(1994). New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae . Yeast (Chichester, England).